Kukje Pharma Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 119,745.57 million compared to KRW 130,394.72 million a year ago. Net loss was KRW 1,559.13 million compared to net income of KRW 2,203 million a year ago.

Basic loss per share from continuing operations was KRW 80.9524 compared to basic earnings per share from continuing operations of KRW 114.2857 a year ago. Diluted loss per share from continuing operations was KRW 80.9524 compared to diluted earnings per share from continuing operations of KRW 114.2857 a year ago. Basic loss per share was KRW 80.9524 compared to basic earnings per share of KRW 114.2857 a year ago.